The American Society of Breast Surgeons (ASBrS) Annual meeting is the premier event of the year for surgeons who treat breast disease: hosting thousands of surgeons, medical device companies, thought leaders, and academics seeking the latest advancements and learnings in breast surgery. Leaders gathered together in Las Vegas from April 26 to 30. This year the annual meeting boasted attendance of over 1700 – the highest attended edition yet.
In addition to catching up with existing and prospective MarginProbe advocates, here are a few of Dilon’s highlights and insights from ASBrS 2017.
New data displaying effectiveness of MarginProbe
During ASBrS MarginProbe was the subject of two separate poster presentations observing the impact of utilizing a real-time, intraoperative radiofrequency probe for margin assessment in breast conserving surgery. The data from both St. John Providence in Michigan and Mier Hospital in Israel showed that the MarginProbe shows great potential in improving re-excision rates benefiting the patient, surgeon and the health system as a whole.
Talking clean margins with Dr. Dennis Holmes, MD
Following our sponsored breakfast Negative margins in TARGiT IORT: Methods and techniques for achieving the most favorable result with Dr. Dennis Holmes, M.D., Stephanie Valente, D.O., Calvin Ridgeway, M.D., Patricia Malinger, M.D., Dr. Holmes was able to talk with the Co-Founder of Breast Cancer Answers, Todd Hartley, live on Facebook.
Their conversation covered multiple subjects: what patients need to know about lumpectomy, when diagnosed with breast cancer what is the path to treatment, and how surgeons ensure clear margins during surgery. Dr. Holmes is a MarginProbe advocate, and used this opportunity to talk about his experience utilizing RF spectroscopy to make sure he gets all the cancer during the first surgery.
“Some surgeons achieve clear margins by taking more tissue and extending the margins but that can cause trouble with cosmesis. Fortunately, we have new devices such as the MarginProbe device that allows us to see the surgical margins at the time of the operation which is important for two reasons: 1. We can be confident about the tissue we are taking out during surgery. And 2. we can take out less tissue, be sure it is clear, and reduce the odds that re-excision will take place.”
The Dilon Devices team is already counting down the days to ASBrS 2018! Until the society convenes next year, for more information about Dilon Devices and MarginProbe, contact firstname.lastname@example.org.